<p>药明康德 (TSE:MX - 获取免费报告) NASDAQ: MEOH 董事 Karine Delbarre 于 3 月 11 日星期二购买了 1,081 股公司的股票。该股票的平均购买价格为每股 53.07 加元，总价值为 57,368.72 加元。</p>
<h2>药明康德价格表现</h2>
<p>MX 在星期三的交易时段上涨了 0.23 加元，达到了 52.87 加元。该公司的股票交易量为 121,409 股，而其平均交易量为 163,652 股。该股票的市值为 25.2 亿加元，市盈率为 16.61，市盈增长比率为 0.44，贝塔值为 1.79。该公司的 50 日移动平均价格为 68.13 加元，200 日移动平均价格为 63.02 加元。公司当前比率为 1.34，速动比率为 1.59，债务股本比率为 148.53。药明康德的 12 个月低点为 49.21 加元，12 个月高点为 78.18 加元。</p>
<h2>华尔街分析师观点</h2>
<p>几家研究公司最近对 MX 发布了报告。Cibc World Mkts 在 12 月 10 日星期二的报告中将药明康德的股票评级从 “持有” 上调至 “强烈买入”。Scotiabank 在周一将药明康德的股票评级从 “强烈买入” 下调至 “持有”。两位股票研究分析师对该股票给予了持有评级，三位分析师则给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “买入”。</p>
<p><strong>获取我们关于 MX 的最新报告</strong></p>
<h2>关于药明康德</h2>
<p>(获取免费报告)</p>
<p>药明康德公司在中国、欧洲、美国、南美、韩国、加拿大和亚洲生产和供应甲醇。该公司还根据甲醇购买合同和现货市场购买其他公司生产的甲醇。此外，它拥有并租赁储存和终端设施。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过药明康德</li>
<li>ETF 会支付股息吗？你需要知道的事项</li>
<li>NVIDIA 激增的能源需求使这三只核能股票成为买入</li>
<li>最佳股票低于 10.00 美元</li>
<li>为什么能源转移应该在你的观察名单上</li>
<li>医疗保健股票解析：为什么你可能想要投资</li>
<li>为什么 Wayfair 股票可能是价值投资者的隐藏宝石</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PVRTRSZTeW1ib2w9TVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PVRTRSZTeW1ib2w9TVg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在药明康德吗？</h2>
<p>在考虑药明康德之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前立即购买……而药明康德并不在名单上。</p>
<p>虽然药明康德目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

梅思恩

<p>Methanex 公司（TSE:MX）董事 Karine Delbarre 以平均价格 C$53.07 购买了 1,081 股，总计 C$57,368.72。该股票上涨 C$0.23 至 C$52.87，市值为 C$25.2 亿。分析师的评级不一，Cibc World Mkts 将评级上调至 “强烈买入”，而 Scotiabank 则下调至 “持有”。Methanex 在分析师中获得的共识评级为 “买入”。该公司在全球范围内生产和供应甲醇，其股票的 12 个月价格区间为 C$49.21 至 C$78.18</p>

<p>Methanex Co. (TSE:MX - Get Free Report) NASDAQ: MEOH Director Karine Delbarre bought 1,081 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was purchased at an average cost of C$53.07 per share, with a total value of C$57,368.72.</p>
<div class="lb-trans"><p>药明康德 (TSE:MX - 获取免费报告) NASDAQ: MEOH 董事 Karine Delbarre 于 3 月 11 日星期二购买了 1,081 股公司的股票。该股票的平均购买价格为每股 53.07 加元，总价值为 57,368.72 加元。</p>
</div><h2>Methanex Price Performance</h2>
<div class="lb-trans"><h2>药明康德价格表现</h2>
</div><p>MX traded up C$0.23 during trading hours on Wednesday, hitting C$52.87. The company's stock had a trading volume of 121,409 shares, compared to its average volume of 163,652. The stock has a market cap of C$2.52 billion, a price-to-earnings ratio of 16.61, a P/E/G ratio of 0.44 and a beta of 1.79. The business's 50-day moving average price is C$68.13 and its 200-day moving average price is C$63.02. The company has a current ratio of 1.34, a quick ratio of 1.59 and a debt-to-equity ratio of 148.53. Methanex Co. has a 12 month low of C$49.21 and a 12 month high of C$78.18.</p>
<div class="lb-trans"><p>MX 在星期三的交易时段上涨了 0.23 加元，达到了 52.87 加元。该公司的股票交易量为 121,409 股，而其平均交易量为 163,652 股。该股票的市值为 25.2 亿加元，市盈率为 16.61，市盈增长比率为 0.44，贝塔值为 1.79。该公司的 50 日移动平均价格为 68.13 加元，200 日移动平均价格为 63.02 加元。公司当前比率为 1.34，速动比率为 1.59，债务股本比率为 148.53。药明康德的 12 个月低点为 49.21 加元，12 个月高点为 78.18 加元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several research firms have recently issued reports on MX. Cibc World Mkts raised shares of Methanex from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Tuesday, December 10th. Scotiabank downgraded shares of Methanex from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Monday. Two equities research analysts have rated the stock with a hold rating and three have assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of &#34;Buy&#34;.</p>
<div class="lb-trans"><p>几家研究公司最近对 MX 发布了报告。Cibc World Mkts 在 12 月 10 日星期二的报告中将药明康德的股票评级从 “持有” 上调至 “强烈买入”。Scotiabank 在周一将药明康德的股票评级从 “强烈买入” 下调至 “持有”。两位股票研究分析师对该股票给予了持有评级，三位分析师则给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “买入”。</p>
</div><p><strong>Get Our Latest Report on MX</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 MX 的最新报告</strong></p>
</div><h2>About Methanex</h2>
<div class="lb-trans"><h2>关于药明康德</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Methanex Corporation produces and supplies methanol in China, Europe, the United States, South America, South Korea, Canada, and Asia. The company also purchases methanol produced by others under methanol offtake contracts and on the spot market. In addition, it owns and leases storage and terminal facilities.</p>
<div class="lb-trans"><p>药明康德公司在中国、欧洲、美国、南美、韩国、加拿大和亚洲生产和供应甲醇。该公司还根据甲醇购买合同和现货市场购买其他公司生产的甲醇。此外，它拥有并租赁储存和终端设施。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Methanex</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy</li>
<li>Best Stocks Under $10.00</li>
<li>Why Energy Transfer Belongs on Your Watchlist</li>
<li>Health Care Stocks Explained: Why You Might Want to Invest</li>
<li>Why Wayfair Stock May Be a Hidden Gem for Value Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过药明康德</li>
<li>ETF 会支付股息吗？你需要知道的事项</li>
<li>NVIDIA 激增的能源需求使这三只核能股票成为买入</li>
<li>最佳股票低于 10.00 美元</li>
<li>为什么能源转移应该在你的观察名单上</li>
<li>医疗保健股票解析：为什么你可能想要投资</li>
<li>为什么 Wayfair 股票可能是价值投资者的隐藏宝石</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PVRTRSZTeW1ib2w9TVg" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=TSE&amp;Symbol=MX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Methanex Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在药明康德吗？</h2>
</div><p>Before you consider Methanex, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑药明康德之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Methanex wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前立即购买……而药明康德并不在名单上。</p>
</div><p>While Methanex currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然药明康德目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

梅思恩公司（TSE:MX）的一位董事购买了价值 57,368.72 加元的股票